CoreWeave Soars, Nebius Waits Its Turn

CoreWeave (CRWV) posted $982M in Q1 2025 revenue and secured $14.6B in financing, with its market performance, including a 200%+ surge, fueled by a thin float and retail hype despite 77% revenue concentration from two customers. In contrast, Nebius (NBIS) generated ~$55M in Q1 revenue but exhibits greater financial prudence with $1.45B cash, minimal leverage, and a diversified client base across 20+ industries, projecting EBITDA breakeven by late 2025. This divergence underscores differing investor appetites for aggressive, concentrated growth versus more diversified, financially stable expansion within the AI infrastructure sector, reflected in Nebius's more modest 35% gain.

Analysis

The AI infrastructure market presents a tale of two distinct growth strategies, as illustrated by CoreWeave (CRWV) and Nebius (NBIS). CoreWeave demonstrates hyper-growth, reporting $982 million in Q1 2025 revenue and securing substantial financing, including $2.6 billion in equity and $12 billion in GPU-backed debt. This aggressive expansion, fueled by marquee contracts and significant retail hype, has propelled its stock over 200%. However, this growth is accompanied by significant concentration risk, with 77% of its revenue dependent on just two customers. In contrast, Nebius represents a more conservative and de-risked approach. With approximately $55 million in Q1 revenue, it is at a much earlier stage but boasts a stronger balance sheet, holding $1.45 billion in cash with minimal leverage. Its key strategic advantage is diversification, with a client base spread across more than 20 industries and no single dominant customer. While Nebius's stock has seen a more modest 35% gain, its focus on achieving EBITDA breakeven by late 2025, supported by a $1 billion note and U.S. expansion plans, suggests a fundamentally different, potentially more sustainable, long-term strategy.

Key Decisions for Investors

• Investors in CoreWeave should closely monitor its client concentration, as any disruption with its two key customers poses a material risk to its revenue and high valuation.
• For Nebius, an investment thesis hinges on management's execution toward achieving its stated goal of EBITDA breakeven by late 2025 and successfully penetrating the U.S. market, which would validate its more diversified and financially prudent growth model.
• Consider allocating capital based on risk appetite: CoreWeave offers exposure to explosive but concentrated growth, whereas Nebius presents a de-risked, albeit earlier-stage, play on the same secular AI trend with a wider margin of safety due to its diversified revenue and strong balance sheet.